Papers
2
Total Citations
7
H-Index
1
About
Duocai Li is a clinical researcher whose work focuses on optimizing surgical and multimodal treatment strategies for prostate cancer, with particular emphasis on robot-assisted radical prostatectomy and the management of oligometastatic disease. His major contributions include a pivotal meta-analysis that systematically evaluated the necessity of routine pelvic drain placement after robot-assisted radical prostatectomy, providing evidence-based guidance to reduce unnecessary interventions and improve postoperative recovery. This work, published in 2023, has already garnered 6 citations, reflecting its immediate relevance to urological practice. Li is also leading the NEAR-TOP trial (2025), a multicenter, open-label, randomized controlled study investigating neoadjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer—a protocol that addresses a critical gap in treatment resistance and disease progression. By integrating robotic surgery with precision radiotherapy, his research pushes the boundaries of personalized oncology. With a growing citation impact and a focus on high-quality clinical evidence, Li is emerging as a thoughtful contributor to evidence-based urology and cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2